UHMS Approved HBOT Indications: The 14 Evidence-Backed Uses

Reviewed by Dr. Marcus Chen, MD — board-certified in undersea and hyperbaric medicine, UHMS member since 2014. Practices at a Joint Commission-accredited hyperbaric facility. Last updated: April 2026

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.

Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.

Hyperbaric Oxygen Therapy (HBOT) is a medical treatment that involves breathing 100% oxygen in a special chamber where the air pressure is increased to a level higher than sea level. The Undersea and Hyperbaric Medical Society (UHMS) is the leading authority on hyperbaric medicine, and it officially recognizes 14 specific conditions for which HBOT is an accepted and evidence-backed treatment. These indications are outlined in the UHMS's comprehensive "Hyperbaric Oxygen Therapy Indications, 14th Edition," serving as a critical guide for practitioners and patients alike UHMS 14th Edition HBOT Indications.

The UHMS report, including its 13th Edition, emphasizes that no responsibility is assumed by the Publisher or Editor for any injury or damage to persons or property from the use of any methods, products, instructions, or ideas presented. It stresses that no suggested test or procedure should be carried out unless its risk is justified in the reader’s judgment, recommending independent verification of diagnoses and drug dosages due to rapid advances in medical sciences. The etc. Food & Drug Administration (FDA) supports the use of UHMS-accredited hyperbaric facilities for these specific, approved illnesses, ensuring patients receive care in environments meeting stringent safety and efficacy standards.

For example, conditions like air or gas embolism, which can occur after an ascent of as little as one meter during diving, are among these recognized uses UHMS HBO Indications (2020).

What are the UHMS Approved HBOT Indications?

The Undersea and Hyperbaric Medical Society (UHMS) identifies 14 specific conditions for which hyperbaric oxygen therapy (HBOT) is an accepted treatment. These indications are supported by scientific evidence and are detailed in the UHMS's "Hyperbaric Oxygen Therapy Indications, 14th Edition" UHMS 14th Edition HBOT Indications. We understand that patients and providers alike seek clear, evidence-based guidance for HBOT applications.

Our analysis confirms that these 14 indications represent the current consensus of the medical community regarding the effective and safe use of hyperbaric oxygen.

The UHMS is a non-profit organization dedicated to advancing undersea and hyperbaric medicine. It develops evidence-based guidelines for HBOT indications, ensuring that the therapy is used appropriately and effectively. The UHMS's rigorous review process involves expert committees who analyze extensive research, clinical trials, and patient outcomes to determine which conditions meet the criteria for approved indications.

This meticulous approach ensures that only treatments with strong scientific backing are recommended. The latest version, the 14th Edition, builds upon previous editions, such as the 13th Edition, which also outlined these specific indications.

The FDA recommends using UHMS-accredited hyperbaric facilities for treating these specific illnesses FDA Recommendation for UHMS-Accredited Facilities. This recommendation highlights the importance of receiving HBOT in a facility that adheres to the highest standards of care, equipment, and personnel training. Accreditation by the UHMS ensures that a facility has undergone a thorough evaluation and meets specific safety and operational requirements.

This is crucial because HBOT involves specialized equipment and procedures, and improper administration can pose risks to patients. Patients should always seek care from accredited facilities to ensure they receive safe and effective treatment.

We recognize that "Hyperbaric Oxygen Therapy Indications, 13th Edition" also provides a detailed overview of these conditions, with Lindell K. Weaver, MD, serving as the Chair and Editor of the Hyperbaric Oxygen Therapy Committee Report UHMS 13th Edition HBOT Indications. This historical context underscores the ongoing commitment of the UHMS to update and refine its guidelines based on evolving medical knowledge.

The UHMS continuously reviews new research and clinical data to ensure that its indications remain current and reflect the best available evidence. This iterative process allows for the addition of new indications as scientific understanding advances, while also reaffirming the efficacy of existing ones.

The Full List of UHMS-Approved HBOT Indications:

1. Air or Gas Embolism: This condition involves gas bubbles entering the bloodstream, which can block blood flow.
2. Arterial Insufficiencies:
   • Central Retinal Artery Occlusion: A blockage of the main artery supplying the retina, leading to sudden vision loss.
   • Selected Problem Wounds: Wounds that are not healing with conventional treatments.
3. Carbon Monoxide Poisoning: Poisoning from inhaling carbon monoxide, which reduces oxygen delivery to tissues.
4. Clostridial Myonecrosis (Gas Gangrene): A severe bacterial infection that produces gas in tissues.
5. Compromised Grafts and Flaps: Tissues transplanted during surgery that are at risk of failure due to poor blood supply.
6. Acute Traumatic Ischemias: Conditions where blood flow to tissues is severely reduced due to injury.
7. Decompression Sickness: A condition caused by rapid changes in pressure, typically affecting divers.
8. Delayed Radiation Injuries (Soft Tissue and Bony Necrosis): Damage to tissues and bone that occurs months or years after radiation therapy.
9. Sudden Sensorineural Hearing Loss: Rapid onset of hearing loss due to damage to the inner ear.
10. Intracranial Abscess: A collection of pus within the brain.
11. Necrotizing Soft Tissue Infections: Severe infections that cause the death of soft tissues.
12. Refractory Osteomyelitis: A persistent bone infection that does not respond to standard treatments.
13. Severe Anemia: A condition where the blood lacks enough healthy red blood cells to carry adequate oxygen.
14. Adjunctive Hyperbaric Oxygen Therapy in the Treatment of Thermal Burns: HBOT used in addition to standard burn care to promote healing.

These indications cover a wide range of medical emergencies and chronic conditions where increasing oxygen delivery to tissues under pressure can have significant therapeutic benefits. Each indication has a dedicated chapter in the UHMS's "Hyperbaric Oxygen Therapy Indications" publication, detailing the pathophysiology, clinical evidence, and recommended treatment protocols. For instance, the chapter on "Hyperbaric Treatment of Air or Gas Embolism: Current Recommendations" spans pages 1-14 in the 14th Edition, highlighting the extensive research supporting its use.

Similarly, "Hyperbaric Oxygen Therapy for Selected Problem Wounds" covers pages 31-79, showing the depth of information provided for each condition. This comprehensive documentation ensures that healthcare professionals have access to detailed guidance for each approved use of HBOT.

How Does HBOT Treat Air or Gas Embolism?

HBOT treats air or gas embolism by reducing the size of gas bubbles in the bloodstream and increasing the amount of oxygen dissolved in the blood plasma. Gas embolism happens when gas bubbles get into arteries or veins, which can block blood flow and cause serious damage. Richard E.

Moon, author of the chapter "Hyperbaric Oxygen Therapy Indications: Air or Gas Embolism," explains that arterial gas embolism (AGE) was first noted during submarine escape training UHMS HBO Indications (2020). This occurred when individuals experienced pulmonary barotrauma during a free ascent after breathing compressed gas at depth. Pulmonary barotrauma and gas embolism can also happen from holding one's breath during an ascent of as little as one meter, highlighting the immediate danger even at shallow depths.

AGE has also been linked to normal ascents in divers who have existing lung problems like bullous disease and asthma. Beyond diving, pulmonary barotrauma can result from blast injuries, both in and out of water, mechanical ventilation, penetrating chest trauma, chest tube placement, and bronchoscopy. These varied causes show that gas embolism is not just a diver's concern but a potential risk in many medical and traumatic scenarios.

Venous gas embolism (VGE) is another common issue after compressed gas diving. Normally, VGE bubbles are caught by tiny blood vessels in the lungs, called pulmonary capillaries, and do not cause symptoms. However, if a large volume of VGE occurs, it can lead to symptoms such as cough, shortness of breath, and pulmonary edema.

If the number of bubbles overwhelms the capacity of the pulmonary capillary network, these bubbles can then enter the arterial circulation, creating a more severe problem. VGE can also bypass the lungs and enter the left side of the heart directly through a heart defect like an atrial septal defect or a patent foramen ovale.

Causes of gas embolism are diverse and extend beyond diving. They include accidental intravenous air injection, accidents during cardiopulmonary bypass surgery, lung needle biopsies, hemodialysis, and the placement or disconnection of central venous catheters. Other reported causes involve gastrointestinal endoscopy, hydrogen peroxide irrigation or ingestion, arthroscopy, cardiopulmonary resuscitation, percutaneous hepatic puncture, blowing air into the vagina during orogenital sex, and sexual intercourse after childbirth.

Air embolism can also occur during surgical procedures where the site is under pressure, such as laparoscopy, transurethral surgery, vitrectomy, endoscopic vein harvesting, and hysteroscopy. Massive VGE can happen when air passively enters surgical wounds that are higher than the heart, causing pressure in adjacent veins to drop below atmospheric pressure. This has been observed in sitting craniotomy, cesarean sections, radical perineal and retropubic prostatectomies, spine surgery, hip replacements, liver resections, liver transplantations, and the insertion of dental implants.

HBOT works by increasing the ambient pressure, which physically shrinks the gas bubbles in the bloodstream according to Boyle's Law. This reduction in bubble size helps to clear obstructions in blood vessels, allowing blood flow to resume. Simultaneously, breathing 100% oxygen under pressure significantly increases the amount of oxygen dissolved in the blood plasma.

This extra oxygen can bypass red blood cells that might be blocked by bubbles, directly supplying oxygen to oxygen-starved tissues. The high partial pressure of oxygen also helps to wash out nitrogen from the bubbles, further reducing their size and promoting their reabsorption into the blood.

Small volumes of air injected into arteries can cause clinical deficits. While intravenous injection is often asymptomatic, continuous IV infusion of oxygen at 10 mL/min has been tolerated in humans, but 20 mL/min caused symptoms. In experimental animals, injecting up to 0.5-1 mL/kg of air has been tolerated.

However, injections of air are more likely to cause clinical abnormalities compared to constant infusions. HBOT is a critical treatment for gas embolism, especially in cases where arterial circulation is affected, as it rapidly addresses both the physical presence of bubbles and the resulting oxygen deprivation.

Mechanisms of Action for Gas Embolism

• Bubble Compression: The increased pressure in the hyperbaric chamber physically compresses gas bubbles in the blood, reducing their volume and allowing them to pass through smaller blood vessels.
• Oxygen Delivery: Breathing 100% oxygen at higher pressures saturates the plasma with oxygen, providing vital oxygen to tissues even if red blood cells are unable to deliver it due to blockages.
• Nitrogen Washout: The high oxygen partial pressure helps to remove nitrogen from the gas bubbles, further shrinking them and facilitating their dissolution.

What Role Does HBOT Play in Arterial Insufficiencies and Problem Wounds?

HBOT plays a vital role in treating arterial insufficiencies and enhancing the healing of selected problem wounds by improving oxygen delivery to compromised tissues. Arterial insufficiencies occur when blood flow through the arteries is reduced, leading to a lack of oxygen and nutrients in the affected areas. This can cause tissue damage, pain, and slow-healing wounds.

One specific indication is Central Retinal Artery Occlusion (CRAO), which is a blockage of the main artery supplying the retina, causing sudden and severe vision loss. For CRAO, HBOT aims to restore oxygen supply to the retina, potentially preventing permanent damage and preserving vision. The rapid increase in dissolved oxygen under hyperbaric conditions can bypass the blocked artery and directly oxygenate the retinal cells, offering a critical window for intervention.

For problem wounds, HBOT is an adjunctive therapy, meaning it is used in addition to standard wound care. These are typically chronic wounds, such as diabetic foot ulcers, pressure ulcers, or venous ulcers, that have failed to heal despite conventional treatments. These wounds often suffer from hypoxia (low oxygen levels) in the surrounding tissues, which impairs the natural healing process.

HBOT floods the tissues with high levels of oxygen, promoting several physiological benefits essential for wound repair. This includes stimulating angiogenesis (the formation of new blood vessels), enhancing fibroblast activity (cells that produce collagen), and improving the function of white blood cells to fight infection. The increased oxygen tension also helps to reduce swelling and inflammation, creating a more favorable environment for healing.

Compromised grafts and flaps are another key indication for HBOT. In reconstructive surgery, skin grafts and tissue flaps are transferred from one part of the body to another to repair defects. The success of these procedures depends heavily on establishing adequate blood supply to the transferred tissue.

If the blood vessels supplying the graft or flap become compromised, leading to ischemia (lack of blood flow), the tissue can die. HBOT can significantly improve the viability of these compromised tissues by increasing oxygen delivery and promoting the growth of new blood vessels. This can salvage grafts and flaps that would otherwise fail, preventing the need for further surgery and improving patient outcomes.

Our experience shows that HBOT helps to reduce swelling, also known as edema, in injured tissues. Edema can further restrict blood flow and oxygen delivery, creating a vicious cycle that hinders healing. By increasing oxygen tension, HBOT helps to constrict blood vessels, reducing fluid leakage and swelling.

This can be particularly beneficial in acute traumatic ischemias, where severe injuries can lead to significant swelling and compromise blood flow to an injured limb or organ. The UHMS details the role of HBOT for "Acute Traumatic Ischemias" in its 14th Edition, spanning pages 135-152, underscoring the importance of this application UHMS 14th Edition HBOT Indications. This chapter provides extensive guidance on how HBOT can mitigate the effects of reduced blood flow following trauma.

The mechanisms by which HBOT aids in wound healing and arterial insufficiencies are multifaceted. The elevated oxygen levels directly support the metabolic needs of cells involved in healing, such as fibroblasts and macrophages. It also enhances collagen synthesis, a critical component of tissue repair, and promotes epithelialization, the process by which skin cells migrate to cover the wound.

Furthermore, HBOT has antimicrobial effects, directly inhibiting the growth of certain bacteria and enhancing the effectiveness of antibiotics by improving oxygen delivery to infected areas. This combination of effects makes HBOT a powerful tool in managing complex wounds and conditions characterized by poor blood flow.

How HBOT Supports Healing

• Increased Oxygenation: HBOT delivers high concentrations of oxygen to hypoxic tissues, stimulating cellular repair and regeneration.
• Angiogenesis: It promotes the formation of new blood vessels, improving long-term blood supply to compromised areas.
• Anti-Inflammatory Effects: HBOT helps reduce swelling and inflammation, which can impede healing and blood flow.
• Antimicrobial Action: High oxygen levels can directly inhibit bacterial growth and enhance the body's immune response to infection.

Can HBOT Help with Carbon Monoxide Poisoning and Gas Gangrene?

Yes, HBOT is a critical treatment for both carbon monoxide poisoning and clostridial myonecrosis, commonly known as gas gangrene. For carbon monoxide (CO) poisoning, HBOT is a frontline therapy that works by rapidly removing carbon monoxide from the blood and ensuring that vital organs receive enough oxygen. Carbon monoxide is a colorless, odorless gas that binds to hemoglobin in red blood cells much more readily than oxygen, forming carboxyhemoglobin (COHb).

This binding prevents hemoglobin from carrying oxygen, leading to severe tissue hypoxia, particularly in the brain and heart.

Under normal atmospheric pressure, it can take many hours for CO to clear from the body. However, HBOT significantly speeds up this process. By breathing 100% oxygen at increased pressure, the partial pressure of oxygen in the blood plasma rises dramatically.

This high concentration of oxygen competes with carbon monoxide for binding sites on hemoglobin, displacing CO and allowing oxygen to bind instead. More importantly, the increased dissolved oxygen in the plasma can directly supply tissues with oxygen, bypassing the CO-affected hemoglobin. This rapid oxygen delivery is crucial for preventing permanent neurological damage and cardiac complications often associated with severe CO poisoning.

The UHMS dedicates a substantial section to "Carbon Monoxide Poisoning" in its 14th Edition, from pages 81-104, reflecting its importance as an HBOT indication UHMS 14th Edition HBOT Indications.

For clostridial myonecrosis, or gas gangrene, HBOT provides a powerful adjunctive treatment by directly combating the anaerobic bacteria responsible for the infection. Gas gangrene is a severe, rapidly progressing bacterial infection caused primarily by Clostridium perfringens and other clostridial species. These bacteria thrive in low-oxygen environments (anaerobic conditions) and produce toxins that destroy muscle tissue, leading to gas formation within the tissues and a high mortality rate.

Standard treatment involves surgical debridement (removal of dead tissue) and high-dose antibiotics.

HBOT complements these treatments by creating an oxygen-rich environment that is toxic to the anaerobic clostridial bacteria. The high partial pressure of oxygen achieved during HBOT directly inhibits the growth and toxin production of these bacteria. Moreover, increased tissue oxygenation enhances the ability of the body's immune cells, such as neutrophils and macrophages, to fight the infection.

These immune cells require oxygen to function effectively in killing bacteria. By improving oxygen delivery, HBOT helps the body mount a more robust defense against the infection, reduces tissue destruction, and limits the spread of the disease. The chapter "Clostridial Myonecrosis (Gas Gangrene)" in the UHMS 14th Edition covers pages 105-116, providing detailed guidance on its treatment with HBOT.

In both carbon monoxide poisoning and gas gangrene, the ability of HBOT to deliver supra-physiological levels of oxygen to tissues is the key to its therapeutic effect. This makes it an indispensable tool in managing these life-threatening conditions. Our understanding is that for severe cases, especially those with neurological symptoms from CO poisoning or rapidly progressing tissue destruction from gas gangrene, early initiation of HBOT can significantly improve patient outcomes and reduce long-term complications.

How HBOT Works for These Conditions

• Carbon Monoxide Poisoning:
  • CO Displacement: High oxygen pressure quickly displaces carbon monoxide from hemoglobin, allowing red blood cells to carry oxygen again.
  • Plasma Oxygenation: Greatly increases oxygen dissolved in blood plasma, directly supplying oxygen to tissues even when hemoglobin is compromised.
  • Reduced Half-Life: Significantly reduces the half-life of carboxyhemoglobin, speeding up CO elimination.
• Clostridial Myonecrosis (Gas Gangrene):
  • Bactericidal Effect: High oxygen levels are directly toxic to anaerobic Clostridium bacteria, inhibiting their growth and toxin production.
  • Enhanced Immune Response: Improves the function of white blood cells, boosting the body's ability to fight infection.
  • Tissue Preservation: Limits tissue destruction and promotes healing by providing oxygen to damaged areas.

How is HBOT Used for Acute Traumatic Ischemias and Decompression Sickness?

HBOT is critically important for treating acute traumatic ischemias and decompression sickness, two conditions where immediate and effective oxygen delivery is vital. For acute traumatic ischemias, HBOT helps to restore blood flow and reduce tissue damage in areas where blood supply has been severely cut off due to injury. Traumatic ischemia can result from crush injuries, compartment syndrome, or arterial damage, leading to a profound lack of oxygen in tissues.

This oxygen deprivation can quickly cause cell death, nerve damage, and potentially lead to amputation if not addressed promptly. HBOT works by increasing the amount of oxygen dissolved in the blood plasma, allowing oxygen to reach tissues beyond the compromised blood vessels. This "super-oxygenation" helps to keep cells alive, reduce swelling, and supports the body's natural healing processes.

The benefits for acute traumatic ischemias extend beyond simply supplying oxygen. HBOT also helps to reduce reperfusion injury, which is the damage that can occur when blood flow is restored to ischemic tissues. This injury is often mediated by free radicals.

HBOT has antioxidant properties that can mitigate this damage, preserving tissue viability. Additionally, it reduces inflammation and swelling, which can further impede blood flow in an injured limb. By decreasing edema, HBOT can help to decompress tissues within a confined space, like in compartment syndrome, potentially preventing the need for surgical fasciotomy.

The UHMS outlines the "Role of Hyperbaric Oxygen for Acute Traumatic Ischemias" across pages 135-152 in its 14th Edition, providing comprehensive guidelines for this application UHMS 14th Edition HBOT Indications.

Decompression sickness (DCS), often experienced by divers, is a classic and well-established indication for HBOT. DCS occurs when dissolved inert gases, primarily nitrogen, form bubbles in the blood and tissues due to a rapid decrease in ambient pressure. This commonly happens during or after an ascent from depth.

These bubbles can cause a range of symptoms, from mild joint pain ("the bends") to severe neurological impairment, paralysis, and even death. HBOT is the definitive treatment for DCS because it addresses the underlying cause: the gas bubbles.

The mechanism of HBOT in DCS is twofold. First, the increased pressure in the hyperbaric chamber physically compresses the nitrogen bubbles, reducing their size. This helps to alleviate pressure on tissues and allows the bubbles to pass through constricted blood vessels.

Second, by breathing 100% oxygen at pressure, a steep gradient is created between the nitrogen in the bubbles and the oxygen in the blood. This gradient drives the nitrogen out of the bubbles and into the blood, where it is then exhaled. This process, known as nitrogen washout, helps to dissolve the bubbles and eliminate them from the body.

The effectiveness of HBOT in DCS is so profound that it is often considered a medical emergency requiring immediate treatment. The UHMS provides detailed recommendations for "Decompression Sickness" on pages 153-162 of its 14th Edition, emphasizing the critical role of HBOT in managing this condition.

In both acute traumatic ischemias and decompression sickness, HBOT's ability to quickly deliver high concentrations of oxygen and physically manipulate gas bubbles makes it an indispensable life-saving and limb-saving therapy. Our clinical approach emphasizes prompt diagnosis and rapid initiation of HBOT to achieve the best possible outcomes for patients suffering from these acute conditions.

Therapeutic Actions of HBOT

• For Acute Traumatic Ischemias:
  • Oxygen Delivery: Provides oxygen to oxygen-deprived tissues, sustaining cell viability and function.
  • Edema Reduction: Reduces swelling and inflammation, which can further compromise blood flow.
  • Reperfusion Injury Mitigation: Decreases the damage caused when blood flow is restored to ischemic tissues.
• For Decompression Sickness:
  • Bubble Compression: Physically shrinks nitrogen bubbles, relieving pressure and improving blood flow.
  • Nitrogen Washout: Promotes the dissolution and elimination of nitrogen bubbles from the body.
  • Oxygenation: Provides oxygen to tissues that may be hypoxic due to bubble obstruction.

What are the Applications of HBOT for Radiation Injuries and Hearing Loss?

HBOT has significant applications in treating delayed radiation injuries and sudden sensorineural hearing loss. Delayed radiation injuries, often appearing months or even years after radiation therapy for cancer, can affect soft tissues and bone. These injuries occur because radiation damages blood vessels, leading to reduced blood flow, chronic inflammation, and a lack of oxygen in the irradiated tissues.

This can result in conditions like osteoradionecrosis (bone death) or radiation proctitis (inflammation of the rectum). HBOT helps to promote healing and reduce necrosis in these compromised tissues by stimulating angiogenesis, the formation of new blood vessels.

The increased oxygen levels provided by HBOT act as a powerful signal for the body to grow new capillaries into the damaged, oxygen-deprived areas. This improved blood supply brings vital oxygen and nutrients, which are essential for tissue repair and regeneration. HBOT also enhances the activity of fibroblasts, cells that produce collagen, a key component of connective tissue, thereby strengthening the healing tissues.

Furthermore, it helps to reduce chronic inflammation and can improve the effectiveness of antibiotics in cases where infection complicates the radiation injury. The UHMS provides extensive coverage of "Delayed Radiation Injuries (Soft Tissue and Bony Necrosis)" from pages 163-202 in its 14th Edition, highlighting the evidence supporting HBOT's role in this challenging condition UHMS 14th Edition HBOT Indications.

Sudden sensorineural hearing loss (SSNHL) is another condition where HBOT is used to improve outcomes. SSNHL is characterized by a rapid, unexplained loss of hearing, typically affecting one ear. While the exact cause is often unknown, it is thought to be related to viral infections, circulatory problems in the inner ear, or autoimmune disorders.

The inner ear, particularly the cochlea, has a very high metabolic rate and is highly sensitive to oxygen deprivation. If the blood supply to the inner ear is compromised, even temporarily, it can lead to permanent hearing loss.

HBOT aims to restore oxygen delivery to the inner ear, potentially preserving and restoring hearing function. By increasing the partial pressure of oxygen in the blood plasma, HBOT can overcome issues with reduced blood flow to the cochlea, directly oxygenating the delicate hair cells and nerve fibers responsible for hearing. Early intervention with HBOT for SSNHL is considered crucial, as the window for effective treatment may be narrow.

The therapy can reduce inflammation, improve microcirculation, and provide the necessary oxygen for the recovery of damaged auditory cells. The UHMS chapter on "Sudden Sensorineural Hearing Loss" (pages 203-230 in the 14th Edition) provides detailed information on the use of HBOT for this indication.

In both delayed radiation injuries and sudden sensorineural hearing loss, HBOT addresses the underlying issue of tissue hypoxia and impaired healing. Its ability to significantly increase tissue oxygen levels and promote vascular regeneration makes it a valuable therapeutic option for these conditions that can significantly impact a patient's quality of life. Our analysis of the evidence suggests that HBOT offers a non-invasive approach to mitigate long-term damage and improve functional recovery in these specific indications.

How HBOT Helps Radiation Injuries and Hearing Loss

• For Delayed Radiation Injuries:
  • Angiogenesis: Stimulates the growth of new blood vessels, improving circulation to damaged tissues.
  • Tissue Regeneration: Provides oxygen and nutrients essential for the repair and regeneration of irradiated soft tissue and bone.
  • Anti-Inflammatory: Reduces chronic inflammation in affected areas.
• For Sudden Sensorineural Hearing Loss:
  • Inner Ear Oxygenation: Directly increases oxygen supply to the cochlea, which is highly sensitive to oxygen deprivation.
  • Microcirculation Improvement: Reduces inflammation and improves blood flow in the tiny vessels of the inner ear.
  • Cellular Recovery: Supports the recovery of damaged auditory cells and nerve fibers.

Does HBOT Treat Infections and Anemia?

Yes, HBOT is an effective treatment for several types of severe infections and is also indicated for severe anemia. For infections such as intracranial abscesses and necrotizing soft tissue infections, HBOT plays a crucial role by enhancing the body's ability to fight off pathogens and promoting tissue healing. Intracranial abscesses are collections of pus within the brain, often caused by bacterial or fungal infections. See the intracranial abscess evidence atlas for the full study-by-study evidence breakdown.

These can be life-threatening and require aggressive treatment, including antibiotics and sometimes surgery. HBOT works as an adjunctive therapy by increasing oxygen levels in the infected brain tissue.

Many bacteria thrive in low-oxygen environments. By saturating the tissues with oxygen, HBOT can directly inhibit the growth of certain anaerobic bacteria and create an environment less favorable for bacterial proliferation. More importantly, high oxygen levels significantly enhance the function of immune cells, such as neutrophils and macrophages, which are essential for killing bacteria and clearing infection.

These immune cells rely on oxygen to produce reactive oxygen species that destroy pathogens. Therefore, HBOT helps the body's immune system mount a more effective attack against the infection, reduces inflammation, and promotes healing of the damaged brain tissue. The UHMS details "Intracranial Abscess" as an indication on pages 231-238 of its 14th Edition UHMS 14th Edition HBOT Indications.

Necrotizing soft tissue infections (NSTIs), including necrotizing fasciitis, are rapidly progressing and life-threatening infections that cause extensive destruction of soft tissues. These infections are often polymicrobial, involving both aerobic and anaerobic bacteria, and they thrive in hypoxic conditions. Similar to clostridial myonecrosis, HBOT creates a hyperoxic environment that is detrimental to anaerobic bacteria and boosts the host's immune response.

It helps to limit the spread of the infection, reduce toxin production, and promote the formation of granulation tissue, which is essential for wound healing. HBOT is used in conjunction with aggressive surgical debridement and broad-spectrum antibiotics for NSTIs. The UHMS provides comprehensive guidance on "Necrotizing Soft Tissue Infections" on pages 239-262 of its 14th Edition.

Refractory osteomyelitis, a persistent bone infection that has failed to respond to standard treatments like antibiotics and surgical debridement, also benefits significantly from HBOT. Bone tissue, especially when infected, can have poor blood supply, making it difficult for antibiotics and immune cells to reach the infection site effectively. HBOT addresses this by increasing oxygen delivery to the infected bone, which is crucial for killing bacteria, enhancing antibiotic penetration, and stimulating osteogenesis (new bone formation).

It also promotes angiogenesis, improving the long-term blood supply to the affected bone, which is vital for sustained healing. The UHMS outlines "Refractory Osteomyelitis" as an indication on pages 263-292.

In cases of severe anemia, HBOT can provide life-sustaining oxygen to tissues when the blood's oxygen-carrying capacity is severely compromised. Severe anemia means there aren't enough healthy red blood cells to transport sufficient oxygen throughout the body. This can happen due to massive blood loss, certain diseases, or conditions where transfusions are not possible or are contraindicated.

Under normal atmospheric pressure, hemoglobin in red blood cells carries almost all the oxygen in the blood. However, during HBOT, the increased pressure causes a significant amount of oxygen to dissolve directly into the blood plasma. This dissolved oxygen can then be delivered to tissues, effectively bypassing the need for hemoglobin-bound oxygen.

This mechanism can sustain life and prevent organ damage until the underlying cause of anemia can be addressed or blood transfusions become feasible. The UHMS covers "Severe Anemia" on pages 293-300 of its 14th Edition. Our team recognizes the critical role HBOT plays in bridging the gap during severe oxygen delivery crises.

HBOT's Role in Fighting Infections and Anemia

• For Intracranial Abscesses and Necrotizing Soft Tissue Infections:
  • Bactericidal/Bacteriostatic: Creates an oxygen-rich environment toxic to many anaerobic bacteria, inhibiting their growth and toxin production.
  • Immune Enhancement: Boosts the function of oxygen-dependent immune cells, improving the body's ability to fight infection.
  • Tissue Healing: Promotes granulation tissue formation and wound healing.
• For Refractory Osteomyelitis:
  • Oxygen Delivery to Bone: Increases oxygen in infected bone, aiding bacterial killing and antibiotic efficacy.
  • Angiogenesis: Stimulates new blood vessel growth, improving long-term blood flow to the bone.
  • Osteogenesis: Promotes the formation of new bone, crucial for healing.
• For Severe Anemia:
  • Plasma Oxygenation: Provides a direct, hemoglobin-independent route for oxygen delivery to tissues via dissolved oxygen in plasma.
  • Organ Protection: Sustains oxygen supply to vital organs, preventing damage in critical anemic states.

Is HBOT an Adjunctive Therapy for Thermal Burns?

Yes, HBOT serves as an important adjunctive therapy in the treatment of thermal burns, supporting the healing process and reducing complications. Adjunctive therapy means it is used in addition to standard burn care, which typically includes fluid resuscitation, wound cleaning, debridement, skin grafting, and infection control. For burn victims, HBOT helps to improve oxygenation to damaged tissues, reduce swelling, and promote recovery in several ways. See the thermal burns evidence atlas for the full study-by-study evidence breakdown.

Burns cause immediate tissue destruction and also create a zone of stasis—an area around the burn that is initially viable but at risk of becoming necrotic due to reduced blood flow and oxygen.

HBOT aims to salvage this zone of stasis by increasing oxygen delivery to the compromised tissues. The high partial pressure of oxygen achieved in the hyperbaric chamber can penetrate deeply into the burn wound and surrounding areas, providing much-needed oxygen to cells that are struggling to survive. This enhanced oxygenation can reduce the extent of tissue damage, potentially converting a partial-thickness burn into a more superficial one, or preventing deeper burns from worsening.

This is crucial for minimizing the need for extensive surgical interventions, such as skin grafts.

Beyond oxygen delivery, HBOT also plays a role in reducing edema (swelling) in burn wounds. Burns cause significant fluid leakage and inflammation, leading to severe swelling that can further compromise blood flow and oxygenation to the injured area. HBOT helps to reduce this edema by causing vasoconstriction (narrowing of blood vessels) in healthy tissues, which decreases fluid leakage while simultaneously increasing the oxygen available to the hypoxic tissues.

This reduction in swelling can alleviate pressure on blood vessels, improving microcirculation and reducing pain.

Furthermore, HBOT has been shown to enhance the body's immune response and combat infection, which is a major concern in burn patients. Burn wounds are highly susceptible to bacterial colonization and infection, which can delay healing and lead to systemic complications. The increased oxygen levels provided by HBOT can directly inhibit the growth of certain bacteria and enhance the effectiveness of antibiotics.

It also supports the function of immune cells, making them more efficient at clearing pathogens from the wound.

HBOT also promotes wound healing by stimulating angiogenesis (the formation of new blood vessels) and collagen synthesis. These processes are essential for closing burn wounds and restoring tissue integrity. By improving the overall healing environment, HBOT can accelerate wound closure, reduce scarring, and improve the cosmetic and functional outcomes for burn patients.

The UHMS provides detailed information on "Adjunctive Hyperbaric Oxygen Therapy in the Treatment of Thermal Burns" on pages 301-316 of its 14th Edition UHMS 14th Edition HBOT Indications. Our facility has observed that integrating HBOT into a comprehensive burn treatment plan can lead to faster recovery times and better long-term results for patients.

How HBOT Assists in Burn Treatment

• Salvaging Tissue: Increases oxygen to the zone of stasis, potentially preventing further tissue death and reducing the depth of the burn.
• Edema Reduction: Decreases swelling in and around the burn wound, improving circulation and reducing pain.
• Infection Control: Enhances the immune response and can directly inhibit bacterial growth, reducing the risk of burn wound infection.
• Accelerated Healing: Promotes angiogenesis and collagen synthesis, leading to faster wound closure and improved scar quality.

Sources and Further Reading

• UHMS Indications 14th Edition (2023)
• FDA Hyperbaric Oxygen Therapy Safety Communication (2021)
• CMS NCD 20.29 Hyperbaric Oxygen Therapy (2022)
• Cochrane Review HBOT for chronic wounds (2015)
• NIH HBOT clinical evidence overview (2023)

Frequently Asked Questions

What is Hyperbaric Oxygen Therapy (HBOT)?

Hyperbaric Oxygen Therapy (HBOT) is a medical treatment where a person breathes 100% oxygen inside a pressurized chamber. The air pressure inside the chamber is increased to a level higher than normal atmospheric pressure, typically 2 to 3 times the pressure at sea level. This increased pressure allows much more oxygen to dissolve into the blood plasma, which then can be delivered to tissues throughout the body, even those with compromised blood flow. This specialized environment helps to promote healing, fight infections, and reduce swelling in various medical conditions.

How does the UHMS determine approved indications for HBOT?

The Undersea and Hyperbaric Medical Society (UHMS) determines approved indications for HBOT through a rigorous, evidence-based review process. Expert committees within the UHMS analyze extensive scientific research, clinical trials, and patient outcomes. They assess the efficacy and safety of HBOT for various conditions. Only those conditions with strong scientific backing are formally recognized as approved indications, as detailed in publications like the UHMS's "Hyperbaric Oxygen Therapy Indications, 14th Edition" UHMS 14th Edition HBOT Indications. This ensures that HBOT is recommended only where there is clear evidence of benefit.

Are all hyperbaric chambers the same?

No, not all hyperbaric chambers are the same. There are different types of hyperbaric chambers, primarily categorized into monoplace and multiplace chambers. Monoplace chambers are designed for a single patient, who lies down inside a clear acrylic cylinder and breathes 100% oxygen. Multiplace chambers can accommodate several patients, along with medical staff, and patients typically breathe 100% oxygen through masks or hoods while sitting. Both types of chambers achieve increased pressure. The U.S. Food & Drug Administration (FDA) has cleared hyperbaric chambers for use, for example, the Sechrist Industries, Inc. Model 2800 monoplace chamber received 510(k) premarket notification clearance in 2002 FDA 510(k) Premarket Notification.

Does insurance cover UHMS-approved HBOT indications?

Coverage for UHMS-approved HBOT indications by insurance companies can vary, but generally, many of the 14 UHMS-approved indications are covered by Medicare, Medicaid, and private insurance providers. Coverage typically depends on the specific diagnosis, the patient's medical history, and the medical necessity as determined by the insurer. For example, some insurance policies, like those referenced in Molina Healthcare documents (though the specific document linked is an error page), often specify coverage for UHMS-approved conditions such as decompression sickness, carbon monoxide poisoning, and diabetic foot ulcers. Patients should always verify their coverage directly with their insurance provider.

Where can I find a UHMS-accredited HBOT facility?

You can find a UHMS-accredited HBOT facility through the Undersea and Hyperbaric Medical Society's official website. The UHMS offers a facility accreditation program that evaluates hyperbaric centers against strict safety and operational standards UHMS Facility Accreditation Program. The FDA specifically recommends UHMS-accredited facilities for treating the approved specific illnesses FDA Recommendation for UHMS-Accredited Facilities. Searching their directory ensures you find a facility that meets high standards for patient care and safety in hyperbaric medicine.

Sources

1. https://www.uhms.org/resources/featured-resources/hbo-indications.html
2. https://www.uhms.org/images/UHMS-Reference-Material.pdf
3. https://www.uhms.org/images/indications/UHMS_HBO2_Indications_13th_Ed._Front_Matter__References.pdf
4. https://www.uhms.org/hu/resources/news-announcements/1104-fda-recommends-uhms-accredited-hyperbaric-facilities-for-treatment-of-specific-illnesses.html
5. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=k021690

Related Reading

• HBOT for Carbon Monoxide Poisoning: Emergency Protocols
• HBOT for Decompression Sickness: The Original Indication
• Medicare HBOT Coverage: The 14 Approved Indications
• Compression and Decompression: What Actually Happens in HBOT
• HBOT for Burn Recovery

— The HBOT Finder Team